300759.SZ

Pharmaron Beijing Co., Ltd. [300759.SZ] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

300759.SZ Stock Summary

Top 10 Correlated Stocks

300759.SZ


In the News

300759.SZ Financial details

Company Rating
Strong Buy
Market Cap
35.7B
Income
1.55B
Revenue
11.42B
Book val./share
6.92
Cash/share
1.73
Dividend
0.3
Dividend %
1.15%
Employees
19.48K
Optionable
No
Shortable
Yes
Earnings
28 Mar 2024
P/E
19.85
Forward P/E
14.91
PEG
-16.35
P/S
3.64
P/B
2.59
P/C
11.81
P/FCF
-56.89
Quick Ratio
1.54
Current Ratio
1.94
Debt / Equity
0.52
LT Debt / Equity
0.42
-
-
EPS (TTM)
1.23
EPS next Y
1.37
EPS next Q
-
EPS this Y
-17.14%
EPS next Y
11.61%
EPS next 5Y
-
EPS last 5Y
25.01%
Revenue last 5Y
28.69%
Revenue Q/Q
0.14%
EPS Q/Q
-43.24%
-
-
-
-
SMA20
-
SMA50
-18.52%
SMA100
-26.67%
Inst Own
-
Inst Trans
-
ROA
7%
ROE
14%
ROC
0.1%
Gross Margin
36%
Oper. Margin
16%
Profit Margin
14%
Payout
26%
Shs Outstand
1.61B
Shs Float
837.75M
-
-
-
-
Target Price
-
52W Range
18.5-40.426666
52W High
-48.93%
52W Low
+13.5%
RSI
35
Rel Volume
0.84
Avg Volume
29.83M
Volume
25.19M
Perf Week
-10.55%
Perf Month
-1.3%
Perf Quarter
-
Perf Half Y
-29.5%
-
-
-
-
Beta
0.623
-
-
Volatility
0.9%, 1.12%
Prev Close
1.14%
Price
20.43
Change
-0.97%

300759.SZ Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
3.283.794.316.148.67
Net income per share
0.380.550.991.371.16
Operating cash flow per share
0.830.951.391.71.81
Free cash flow per share
0.110.190.28-0.03-0.68
Cash per share
0.364.693.244.21.89
Book value per share
2.637.847.468.358.91
Tangible book value per share
2.057.286.056.196.21
Share holders equity per share
2.637.847.468.358.91
Interest debt per share
1.681.130.94.425.31
Market cap
4.34B22.7B63.66B76.18B53.68B
Enterprise value
5.44B19.28B61.77B77.92B58.3B
P/E ratio
12.841.4954.345.8639.05
Price to sales ratio
1.496.0412.410.235.23
POCF ratio
5.8924.1938.6237.0225.05
PFCF ratio
45.1123.41191.31-2.19K-66.51
P/B Ratio
1.862.927.187.525.09
PTB ratio
1.862.927.187.525.09
EV to sales
1.875.1312.0310.475.68
Enterprise value over EBITDA
7.7618.8237.93022.3
EV to operating cash flow
7.3720.5437.4737.8627.21
EV to free cash flow
56.47104.81185.63-2.24K-72.24
Earnings yield
0.080.020.020.020.03
Free cash flow yield
0.020.010.010-0.02
Debt to equity
0.610.130.120.520.58
Debt to assets
0.310.10.090.290.3
Net debt to EBITDA
1.56-3.34-1.160.671.77
Current ratio
1.024.682.82.91.67
Interest coverage
5.317.6655.523.0410.1
Income quality
2.171.771.441.271.58
Dividend Yield
0.020.01000.01
Payout ratio
0.220.260.120.170.29
Sales general and administrative to revenue
0.040.060.060.030.07
Research and developement to revenue
0.010.020.020.020.03
Intangibles to total assets
0.110.060.150.150.17
Capex to operating cash flow
-0.87-0.8-0.8-1.02-1.38
Capex to revenue
-0.22-0.2-0.26-0.28-0.29
Capex to depreciation
-3.03-2.38-3.51-4.2-4.24
Stock based compensation to revenue
000.010.010.02
Graham number
4.769.8712.8616.0415.25
ROIC
0.080.060.110.10.08
Return on tangible assets
0.080.060.120.110.08
Graham Net
-1.533.431.65-1.22-4.34
Working capital
24.85M4.67B3.56B5.66B2.62B
Tangible asset value
1.81B7.21B7.2B7.51B7.35B
Net current asset value
-1B3.85B2.57B549.68M-3.12B
Invested capital
0.610.130.120.520.58
Average receivables
661.85M883.46M1.15B1.41B1.95B
Average payables
99.93M113.1M154.74M253.52M360.94M
Average inventory
106.86M138.93M219.51M480.83M860.75M
Days sales outstanding
92.02100.4389.8376.7382.92
Days payables outstanding
20.1217.7721.7724.1722.83
Days of inventory on hand
22.3923.7132.0252.0958.5
Receivables turnover
3.973.634.064.764.4
Payables turnover
18.1420.5416.7615.115.99
Inventory turnover
16.315.3911.47.016.24
ROE
0.150.070.130.160.13
Capex per share
-0.72-0.76-1.11-1.73-2.49

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
3.52.422.312.471.7
Net income per share
0.470.350.30.370.21
Operating cash flow per share
0.470.350.30.640.44
Free cash flow per share
-0.64-0.28-0.370.030.01
Cash per share
3.461.892.162.671.73
Book value per share
13.158.919.39.776.92
Tangible book value per share
9.176.216.577.365.33
Share holders equity per share
13.158.919.39.776.92
Interest debt per share
7.275.25.265.213.62
Market cap
28.5B53.68B38.53B30.12B53.52B
Enterprise value
32.16B58.3B42.63B33.71B57.65B
P/E ratio
18.9732.4527.6617.237.91
Price to sales ratio
10.318.7514.1510.3318.33
POCF ratio
75.86129.82110.6440.1571.44
PFCF ratio
-55.96-159.19-88.26883.135.65K
P/B Ratio
2.745.093.512.614.5
PTB ratio
2.745.093.512.614.5
EV to sales
11.6220.3615.6511.5619.74
Enterprise value over EBITDA
79.5689.6694.9359.34136.91
EV to operating cash flow
85.62140.99122.4144.9476.95
EV to free cash flow
-63.16-172.89-97.64988.436.09K
Earnings yield
0.010.010.010.010.01
Free cash flow yield
-0.02-0.01-0.0100
Debt to equity
0.550.580.560.530.52
Debt to assets
0.290.30.290.270.28
Net debt to EBITDA
9.067.19.136.329.81
Current ratio
1.821.671.671.841.94
Interest coverage
8.6210.929.2211.429.2
Income quality
1111.712.12
Dividend Yield
00000.01
Payout ratio
0.170.030.040.031.04
Sales general and administrative to revenue
0.27-0.10.15-0.010.28
Research and developement to revenue
0.030.040.030.040.04
Intangibles to total assets
0.170.170.170.160.16
Capex to operating cash flow
-2.36-1.82-2.25-0.95-0.99
Capex to revenue
-0.32-0.26-0.29-0.25-0.25
Capex to depreciation
2.79-1.09-3.26-2.971.68
Stock based compensation to revenue
0.020.0300.040.01
Graham number
11.858.377.869.035.65
ROIC
0.020.020.020.020.02
Return on tangible assets
0.020.020.020.020.02
Graham Net
-5.27-4.34-4.01-3.74-2.45
Working capital
3.01B2.62B2.62B3.39B3.51B
Tangible asset value
7.26B7.35B7.76B8.69B9.18B
Net current asset value
-2.51B-3.12B-3.21B-2.65B-2.53B
Invested capital
0.550.580.560.530.52
Average receivables
2.19B2.33B2.47B2.64B2.71B
Average payables
465.74M435.72M417.51M422.58M408.72M
Average inventory
970.79M1.03B1.06B1.06B1.02B
Days sales outstanding
75.7473.386.2282.4884.41
Days payables outstanding
24.7720.3622.0620.3519.08
Days of inventory on hand
54.2152.1855.1950.7847.35
Receivables turnover
1.191.231.041.091.07
Payables turnover
3.634.424.084.424.72
Inventory turnover
1.661.721.631.771.9
ROE
0.040.040.030.040.03
Capex per share
-1.12-0.63-0.67-0.61-0.43

300759.SZ Frequently Asked Questions

What is Pharmaron Beijing Co., Ltd. stock symbol ?

Pharmaron Beijing Co., Ltd. is a CN stock and trading under the symbol 300759.SZ

What is Pharmaron Beijing Co., Ltd. stock quote today ?

Pharmaron Beijing Co., Ltd. stock price is $20.43 today.

Is Pharmaron Beijing Co., Ltd. stock public?

Yes, Pharmaron Beijing Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Similar Market Cap